Brief: Point72 Asset Management, L.P. Reports 6.6% Passive Stake In Celldex Therapeutics
Nov 20 (Reuters) - Celldex Therapeutics Inc CLDX.O :
* POINT72 ASSET MANAGEMENT, L.P. REPORTS 6.6% PASSIVE STAKE
IN
CELLDEX THERAPEUTICS AS OF NOVEMBER 10- SEC FILING
Source text for Eikon: ID:
Further company coverage: CLDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Celldex Therapeutics
See all newsUS RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
U.S. STOCKS ON THE MOVE-Greenland Mines, GameStop, Shopify
Celldex shares slip as safety concerns cloud skin drug trial win (updated)
Celldex falls after two probable anaphylaxis cases in trials
Celldex's skin disease drug meets goals in two late-stage trials